Found 32 matching trials
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer PHASE3 The study is being conducted to evaluate the efficacy, and safety of camrel...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC. PHASE3 The study is being conducted to evaluate the Famitinib with Camrelizumab pl...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial
A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC. PHASE3 The study is being conducted to evaluate the efficacy and safety of SHR-121...
Show More Location
Beijing Cancer Hosipital
Learn More & Join Trial
An Exploratory Clinical Study of SHR6390 and SHR1020 in the Treatment of Esophageal Squamous Cell Carcinoma After Progression on PD-1 Antibody PHASE2 This study is being conducted to explore the efficacy of SHR-6390 and SHR-1...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer PHASE3 This study is a randomized, open-label, controlled, multi-center Phase III ...
Show More Status
Active Not Recruiting
Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and Camrelizumab N/A hMe-Seal is a low-input whole-genome cell-free 5hmC sequencing method based...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor PHASE2 This is an open-label, multi-center study to evaluate the anti-tumor activi...
Show More Location
Fudan University Zhongshan Hospital
Learn More & Join Trial
SNF Platform Study of HR+/ HER2-advanced Breast Cancer PHASE2 The purpose of this study is to establish a prospective, multi-center platf...
Show More Location
Breast cancer institute of Fudan University Cancer Hospital
Learn More & Join Trial